Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.
about
Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.Acute myeloid leukemia targets for bispecific antibodies.Phenotyping and Target Expression Profiling of CD34+/CD38- and CD34+/CD38+ Stem- and Progenitor cells in Acute Lymphoblastic Leukemia.Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives
P2860
Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Identification of campath-1 (C ...... 5q-patients with MDS and AML.
@en
type
label
Identification of campath-1 (C ...... 5q-patients with MDS and AML.
@en
prefLabel
Identification of campath-1 (C ...... 5q-patients with MDS and AML.
@en
P2093
P50
P1476
Identification of campath-1 (C ...... 5q-patients with MDS and AML.
@en
P2093
Berthold Streubel
Katharina Blatt
Matthias Mayerhofer
Michael Willmann
Sabine Cerny-Reiterer
Susanne Herndlhofer
Thomas Rülicke
Werner Rabitsch
Wolfgang R Sperr
P304
P356
10.1158/1078-0432.CCR-13-2811
P407
P577
2014-05-05T00:00:00Z